CLN3P, the Batten disease protein, localizes to membrane lipid rafts (detergent-resistant membranes).

[1]  S. Fliesler,et al.  Formation of 7-dehydrocholesterol-containing membrane rafts in vitro and in vivo, with relevance to the Smith-Lemli-Opitz syndrome Published, JLR Papers in Press, November 1, 2003. DOI 10.1194/jlr.M300232-JLR200 , 2004, Journal of Lipid Research.

[2]  A. Rebollo,et al.  Rafts: a simple way to control apoptosis by subcellular redistribution. , 2003, Biochimie.

[3]  C. Martínez-A,et al.  Pathogens: raft hijackers , 2003, Nature Reviews Immunology.

[4]  Haibin Xia,et al.  Membrane topology of CLN3, the protein underlying Batten disease , 2003, FEBS letters.

[5]  M. Haltia.  The Neuronal Ceroid–Lipofuscinoses , 2003, Journal of neuropathology and experimental neurology.

[6]  T. Harris,et al.  Reciprocal raft–receptor interactions and the assembly of adhesion complexes , 2002, BioEssays : news and reviews in molecular, cellular and developmental biology.

[7]  U. Igbavboa,et al.  Brain membrane cholesterol domains, aging and amyloid beta-peptides , 2002, Neurobiology of Aging.

[8]  J. Milbrandt,et al.  Lipid rafts in neuronal signaling and function , 2002, Trends in Neurosciences.

[9]  R. Schultz,et al.  The gene mutated in variant late-infantile neuronal ceroid lipofuscinosis (CLN6) and in nclf mutant mice encodes a novel predicted transmembrane protein. , 2002, American journal of human genetics.

[10]  J. Haines,et al.  Mutations in a novel CLN6-encoded transmembrane protein cause variant neuronal ceroid lipofuscinosis in man and mouse. , 2002, American journal of human genetics.

[11]  R. Hammer,et al.  Disruption of PPT1 or PPT2 causes neuronal ceroid lipofuscinosis in knockout mice , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[12]  M. Lehtovirta,et al.  CLN3 protein is targeted to neuronal synapses but excluded from synaptic vesicles: new clues to Batten disease. , 2001, Human molecular genetics.

[13]  E. Ikonen,et al.  Roles of lipid rafts in membrane transport. , 2001, Current opinion in cell biology.

[14]  Kai Simons,et al.  Lipid rafts and signal transduction , 2000, Nature Reviews Molecular Cell Biology.

[15]  A. Chapelle,et al.  The neuronal ceroid lipofuscinoses in human EPMR and mnd mutant mice are associated with mutations in CLN8 , 1999, Nature Genetics.

[16]  K. Wisniewski,et al.  Analysis of intracellular distribution and trafficking of the CLN3 protein in fusion with the green fluorescent protein in vitro. , 1999, Molecular genetics and metabolism.

[17]  C. Bennett,et al.  Tissue expression and subcellular localization of CLN3, the Batten disease protein. , 1999, Molecular genetics and metabolism.

[18]  G. Sutherland,et al.  The Batten disease gene product (CLN3p) is a Golgi integral membrane protein. , 1999, Human molecular genetics.

[19]  E. Lander,et al.  CLN5, a novel gene encoding a putative transmembrane protein mutated in Finnish variant late infantile neuronal ceroid lipofuscinosis , 1998, Nature Genetics.

[20]  R. Donnelly,et al.  Association of mutations in a lysosomal protein with classical late-infantile neuronal ceroid lipofuscinosis. , 1997, Science.

[21]  E. Ikonen,et al.  Functional rafts in cell membranes , 1997, Nature.

[22]  P. Uvebrant,et al.  Neuronal Ceroid Lipofuscinoses in Scandinavia: Epidemiology and Clinical Pictures , 1997, Neuropediatrics.

[23]  L. Peltonen,et al.  Efficient construction of a physical map by fiber-FISH of the CLN5 region: refined assignment and long-range contig covering the critical region on 13q22. , 1996, Genomics.

[24]  J. Haines,et al.  Isolation of a novel gene underlying batten disease, CLN3 , 1995, Cell.

[25]  R. Kelley.  Diagnosis of Smith-Lemli-Opitz syndrome by gas chromatography/mass spectrometry of 7-dehydrocholesterol in plasma, amniotic fluid and cultured skin fibroblasts. , 1995, Clinica chimica acta; international journal of clinical chemistry.

[26]  J. Weissenbach,et al.  The gene for a recessively inherited human childhood progressive epilepsy with mental retardation maps to the distal short arm of chromosome 8. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[27]  H. Goebel,et al.  Incidence of neuronal ceroid-lipofuscinoses in West Germany: variation of a method for studying autosomal recessive disorders. , 1992, American journal of medical genetics.

[28]  L. Peltonen,et al.  Biosynthesis and intracellular targeting of the CLN3 protein defective in Batten disease. , 1998, Human molecular genetics.

[29]  G. Lepage,et al.  Direct transesterification of all classes of lipids in a one-step reaction. , 1986, Journal of lipid research.